Meta-analysis of efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatmen
Journal Title: TMR Integrative Medicine - Year 2021, Vol 5, Issue 20
Abstract
Objective: To systematically evaluate the efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatment. Methods: Randomized controlled trials of Qianliexin capsule combined with western medicine in the treatment of benign prostatic hyperplasia were searched from PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure, VIP, Wanfang and China Biomedical Literature Databases from establishment of the database to February 2021. Meta-analysis was performed using RevMan5.4 software after two researchers independently screened the literatures, extracted the data and evaluated the bias risks in the included studies according to the Cochrane Collaboration System Evaluator Manual. Results: 6 randomized controlled trials involving 1060 patients were included. Meta-analysis results showed that the treatment group was better than the control group in total effective rate (Relative Risk = 1.19, 95% Confidence Interval (1.10, 1.28), P < 0.00001), International Prostate Symptom Score (Mean Difference = -2.99, 95% confidence interval (-4.00, -1.99) , P < 0.00001), prostate volume (Mean Difference = -3.77, 95% Confidence Interval (-4.67, -2.86), P < 0.00001), postvoid residual urine volume (Mean Difference = -5.96, 95% Confidence Interval (-8.15, -3.77), P < 0.00001) and maximum urine flow rate (Mean Difference = 3.45, 95% Confidence Interval (2.53, 4.37), P < 0.00001). While there was no significant difference in the adverse effects rate (Relative Risk = 0.71, 95% Confidence Interval (0.33, 1.56), P = 0.40) between the treatment group and the control group. Conclusion: Qianliexin capsule combined with western medicine in the treatment of benign prostatic hyperplasia showed good efficacy and high safety. However, more high-quality and large-sample studies are needed to confirm the above conclusions.
Authors and Affiliations
Sheng-Nan Wang, Yi-Hua Fan, Shan Lin, Jin-Rui Wei, Sheng-Xuan Zhao, Qiao Liu, Kai Zhong
Keywords
Related Articles
- EP ID EP697539
- DOI 10.53388/TMRIM202105020
- Views 46
- Downloads 0
Research progress on the regulation of androgen receptor signaling pathway in the treatment of prostate cancer by traditional Chinese medicine monomers
The prevalence of prostate cancer in males worldwide is increasing every year. Androgen and androgen receptor drive the development of prostate cancer and are important targets for the treatment of prostate cancer. A gro...
Research progress on self-efficacy in patients with total hip replacement
Total hip replacement (THR) is an artificial hip joint prosthesis that replaces the damaged femoral head. For the good therapeutic effects, it has been widely used, while also brings a great negative problems at same ti...
A systematic review and meta-analysis to compare the effects of Chinese herbal pieces and granule in different diseaseherbal pieces
Objective: Compared to Chinese herbal piecesherbal pieces, the quality of TCM granule is stable and controllable, it is also a convenient alternative to decocting herbs. However, whether they are as clinically effective...
Antioxidative effect of peroxiredoxin-3 in the rat myocardium exposed to renal ischemia-reperfusion injury
Background: Peroxiredoxin-3 (Prx-3) is known to be involved in the clearance of cellular hydrogen peroxide and plays an important role in protecting the myocardial tissue against damage of oxidative stress. However, the...
Cinnamomum camphora: a long history for epidemics control
Camphor (C10H16O) is a white crystalline solid exist in enantiomeric form R and S camphor. It is a terpenoid obtained from turpentine oil. Synthetically it is synthesized by catalytic process as alpha pinene. Naturally c...